Q2 2016 13F Holders as of 6/30/2016
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
159M
-
Number of holders
-
265
-
Total 13F shares, excl. options
-
108M
-
Shares change
-
+4.3M
-
Total reported value, excl. options
-
$2.52B
-
Value change
-
+$25M
-
Put/Call ratio
-
0.56
-
Number of buys
-
130
-
Number of sells
-
-125
-
Price
-
$23.29
Significant Holders of IONIS PHARMACEUTICALS INC - COMMON STOCK (IONS) as of Q2 2016
358 filings reported holding IONS - IONIS PHARMACEUTICALS INC - COMMON STOCK as of Q2 2016.
IONIS PHARMACEUTICALS INC - COMMON STOCK (IONS) has 265 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 108M shares
of 159M outstanding shares and own 68.39% of the company stock.
Largest 10 shareholders include FMR LLC (18.1M shares), Clearbridge Investments, LLC (11.3M shares), VANGUARD GROUP INC (8.79M shares), BAILLIE GIFFORD & CO (8.66M shares), BB BIOTECH AG (7.1M shares), WADDELL & REED FINANCIAL INC (5.95M shares), STATE STREET CORP (4.25M shares), BlackRock Institutional Trust Company, N.A. (3.06M shares), BlackRock Fund Advisors (2.8M shares), and OppenheimerFunds, Inc. (1.89M shares).
This table shows the top 265 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.